3/18/2018 | 300490000000 | MEDICINE (BMN250 SOLUTION FOR ICV INFUSION (RHNAGLU-IGF2) RECOMBINANT HUMAN N-ACETYL GLUCOSAMINIDASE ALPHA-16F2)
| 50 | Set | 1775.53 | N/A | COVANCE KLINIK ÜRÜNGELISTIRME HIZMETLERI LIMITED SIRKETI |
3/14/2018 | 300490000000 | MEDICINE (BMN250 SOLUTION FOR ICV INFUSION (RHNAGLU-IGF2) RECOMBINANT HUMAN N-ACETYL GLUCOSAMINIDASE ALPHA-16F2)
| 100 | Set | 3348.66 | N/A | COVANCE KLINIK ÜRÜNGELISTIRME HIZMETLERI LIMITED SIRKETI |
3/28/2024 | 300490000000 | 91773QR ALPHAGAN P 0-.15% 5 ML | 165888 | UNIT | 715775 | N/A | ABBVIE TIBBİ İLAÇLAR SANAYİ VE TİCARET LİMİTED ŞİRKETİ |
3/11/2018 | 300490000000 | MEDICINE (BMN250 SOLUTION FOR ICV INFUSION (RHNAGLU-IGF2) RECOMBINANT HUMAN N-ACETYL GLUCOSAMINIDASE ALPHA-16F2)
| 50 | Set | 1769.58 | N/A | COVANCE KLINIK ÜRÜNGELISTIRME HIZMETLERI LIMITED SIRKETI |
3/1/2024 | 300490000000 | ALPHAGAN P 0.15% 5 ML TURKISH PHARMACEUTICAL AND MEDICAL DEVICE AUTHORITY:E-16358815-504.01.01-1209881- 31.08.2023**+ CONTROL CERTIFICATE TPS NO:23243220100851042961263/1-01.09.20 23 | 267192 | UNIT | 1144773 | N/A | ABBVIE TIBBİ İLAÇLAR SANAYİ VE TİCARET LİMİTED ŞİRKETİ |